Consider Steglatro as Another Flozin for Type 2 Diabetes

Steglatro (steh-GLAH-troh, ertugliflozin) will be the fourth SGLT2 inhibitor for type 2 diabetes in Canada....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote